| Type: | combo |
| Component1: | Loteprednol |
| Class1: | Corticosteroid |
| Component2: | Tobramycin |
| Class2: | Aminoglycoside antibiotic |
| Tradename: | Zylet |
| Dailymedid: | Loteprednol and tobramycin |
| Routes Of Administration: | Ophthalmic |
| Atc Prefix: | S01 |
| Atc Suffix: | CA12 |
| Legal Us: | Rx-only |
| Legal Us Comment: | [1] |
| Cas Number: | 863983-05-5 |
| Kegg: | D12133 |
Loteprednol/tobramycin, sold under the brand name Zylet, is a fixed-dose combination medication used for the treatment of inflammation of the eye. It is a combination of loteprednol, as the etabonate, a corticosteroid; and tobramycin, an aminoglycoside antibiotic. It is used as drops in the eye.
Loteprednol/tobramycin was approved for medical use in the United States in December 2004.